Brokers Set Expectations for UNCY Q1 Earnings
Unicycive Therapeutics, Inc. (NASDAQ:UNCY – Free Report) – Analysts at Brookline Capital Management issued their Q1 2025 earnings per share estimates for Unicycive Therapeutics in a research report issued to clients and investors on Tuesday, April 1st. Brookline Capital Management analyst K. Raja expects that the company will earn ($0.15) per share for the quarter. […]
